Oxcarbazepine Tablets Market

Oxcarbazepine Tablets, sold under the brand name Trileptal among others, is a medication used to treat epilepsy and bipolar disorder.
Oxcarbazepine Tablets Market contains market size and forecasts of Oxcarbazepine Tablets in global, including the following market information:
Global Oxcarbazepine Tablets Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Oxcarbazepine Tablets Market Sales, 2017-2022, 2023-2028, (M Unit)
Global top five Oxcarbazepine Tablets companies in 2021 (%)
The global Oxcarbazepine Tablets market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tablets (150mg) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Oxcarbazepine Tablets include Novartis (Trileptal), Supernus Pharmaceuticals (Oxtellar XR), Apotex, Sun Pharm, Jubilant Generics, Taro Pharmaceuticals, Stada Group, Mylan and Teva Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Oxcarbazepine Tablets manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oxcarbazepine Tablets Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Unit)
Global Oxcarbazepine Tablets Market Segment Percentages, by Type, 2021 (%)
Tablets (150mg)
Tablets (300mg)
Tablets (600mg)
Global Oxcarbazepine Tablets Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Unit)
Global Oxcarbazepine Tablets Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Global Oxcarbazepine Tablets Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Unit)
Global Oxcarbazepine Tablets Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oxcarbazepine Tablets revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Oxcarbazepine Tablets revenues share in global market, 2021 (%)
Key companies Oxcarbazepine Tablets sales in global market, 2017-2022 (Estimated), (M Unit)
Key companies Oxcarbazepine Tablets sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis (Trileptal)
Supernus Pharmaceuticals (Oxtellar XR)
Apotex
Sun Pharm
Jubilant Generics
Taro Pharmaceuticals
Stada Group
Mylan
Teva Pharmaceutical
Hikma Pharmaceuticals
ANI Pharmaceuticals
Glenmark Pharmaceuticals
Roxane Laboratories
Nobelpharma
Jamp Pharma
Neuraxpharm
Orion Corporation
SihuanPharm
Humanwell Healthcare
Huikang Pharmaceutical
Nexgen pharma